Amgen Inc vs. Ginkgo Bioworks Holdings, Inc.
Amgen Inc (AMGN) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| AMGN | DNA | |
|---|---|---|
| Market Cap | $217.90 billion | $863.98 million |
| Revenue (TTM) | — | $111.86 million |
| Net Income (TTM) | — | $-290,803,000 |
AMGN leads on 1 of 1 size & scale factors.
Valuation
| AMGN | DNA | |
|---|---|---|
| Price / Book | — | 2.06 |
| Price / Sales | — | 7.72 |
AMGN and DNA split the valuation factors evenly.
Profitability
| AMGN | DNA | |
|---|---|---|
| Net Margin | — | -259.96% |
| Return on Equity | — | -69.19% |
AMGN and DNA split the profitability factors evenly.
Dividend
| AMGN | DNA | |
|---|---|---|
| Dividend Yield | 2.50% | — |
AMGN and DNA split the dividend factors evenly.
Risk & Sentiment
| AMGN | DNA | |
|---|---|---|
| Short Interest | 1.66% | 18.73% |
AMGN leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, DNA overview, DNA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.